This module enables investors to look at Vascular Biogenics various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Interest Expense of 20 K, Operating Expenses of 17.5 M or Research and Development Expense of 13.2 M, but also many exotic indicators such as Book Value per Share of 2.0282, Current Ratio of 6.59 or Debt to Equity Ratio of 0.121. This module is a perfect complement to use when analyzing Vascular Biogenics Valuation or Volatility. It can also complement various Vascular Biogenics Technical models. Also please take a look at analysis of Vascular Biogenics Correlation with competitors.